Salt Lake City, UT, United States of America

Brian Hathaway

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of Utah Research Foundation. Active years: 2013-2016.

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Brian Hathaway

Introduction

Brian Hathaway is an accomplished inventor based in Salt Lake City, Utah. He has made significant contributions to the field of peptide synthesis, holding two patents that showcase his innovative work. His research is primarily focused on methods and compositions related to cyclic peptides.

Latest Patents

Hathaway's latest patents include "Methods and compositions related to cyclic peptide synthesis," which discloses compositions and methods for the cyclization of polymers such as peptides. Another notable patent is also titled "Methods and compositions related to cyclic peptide synthesis," which details compositions and methods for the prenylation of polymers such as peptides. These patents reflect his expertise and dedication to advancing the science of peptide synthesis.

Career Highlights

Brian Hathaway is affiliated with the University of Utah Research Foundation, where he continues to explore innovative solutions in his field. His work has garnered attention for its potential applications in various scientific and medical domains.

Collaborations

Hathaway has collaborated with notable colleagues, including Eric W. Schmidt and James T. Nelson. These partnerships have contributed to the advancement of his research and the development of new methodologies in peptide synthesis.

Conclusion

Brian Hathaway's contributions to cyclic peptide synthesis through his patents and research at the University of Utah Research Foundation highlight his role as a significant innovator in the field. His work continues to inspire advancements in peptide-related technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…